Publications

Sort by: Date | Author | Title

Pareek, M., Johansen, N. D., Modin, D., Loiacono, M. M., Harris, R. C., Dufournet, M., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Claggett, B. L., Janstrup, K. H., Bartholdy, K. V., Bernholm, K. F., Borchsenius, J. I. M. H., Davidovski, F. S., Davodian, L. W., Dons, M., Duus, L. S. ... Biering-Sørensen, T. (2025). Risk of Myocarditis or Pericarditis With High-Dose vs Standard-Dose Influenza Vaccine: A Prespecified Secondary Analysis of the Randomized DANFLU-2 Trial. JAMA Network Open, 8(8), Article e2536889. https://doi.org/10.1001/jamanetworkopen.2025.36889
Pareek, M., Lassen, M. C. H., Johansen, N. D., Christensen, S. H., Aliabadi, N., Skaarup, K. G., Modin, D., Claggett, B. L., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Lindholm, M. G., Jensen, A. M. R., Dons, M., Bernholm, K. F., Davidovski, F. S., Duus, L. S., Ottosen, C. I. ... Biering-Sørensen, T. (2025). Effectiveness of bivalent respiratory syncytial virus prefusion F protein-based vaccine in individuals with or without atherosclerotic cardiovascular disease: the DAN-RSV trial. European Heart Journal, 46(41), 4291-4298. https://doi.org/10.1093/eurheartj/ehaf679
Pareek, M., Johansen, N. D., Modin, D., Loiacono, M. M., Harris, R. C., Dufournet, M., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Claggett, B. L., Janstrup, K. H., Bartholdy, K. V., Bernholm, K. F., Borchsenius, J. I. M. H., Davidovski, F. S., Davodian, L. W., Dons, M., Duus, L. S. ... Biering-Sørensen, T. (2025). High-dose vs. standard-dose inactivated influenza vaccine and cardiovascular outcomes in persons with or without pre-existing atherosclerotic cardiovascular disease: the DANFLU-2 trial. European Heart Journal, 46(41), 4282-4290. https://doi.org/10.1093/eurheartj/ehaf678
Pareek, M., Johansen, N. D., Modin, D., Pardo-Seco, J., Rodriguez-Tenreiro-Sánchez, C., Loiacono, M. M., Harris, R. C., Dufournet, M., van Aalst, R., Chit, A., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Claggett, B. L., Janstrup, K. H., Duran-Parrondo, C., Piñeiro-Sotelo, M., Cribeiro-González, M. ... DANFLU-2 Study Group and GALFLU Trial Team (2026). High-Dose Influenza Vaccination in Atherosclerotic Cardiovascular Disease: A Multinational Pooled Analysis of DANFLU-2 and GALFLU (FLUNITY-HD). Journal of the American College of Cardiology, 87(11), 1374-1380. https://doi.org/10.1016/j.jacc.2025.12.080
Pareek, M., Højbjerg Lassen, M. C., Johansen, N. D., Christensen, S. H., Aliabadi, N., Skaarup, K. G., Modin, D., Claggett, B. L., Henningsen, M. B., Larsen, C. S., Larsen, L., Wiese, L., Dalager-Pedersen, M., Lindholm, M. G., Jensen, A. M. R., Dons, M., Bernholm, K. F., Davidovski, F. S., Duus, L. S. ... Biering-Sørensen, T. (2026). Bivalent RSV Prefusion F Protein–Based Vaccine Effectiveness in Individuals With and Without Diabetes: A Prespecified Analysis of the DAN-RSV Trial. Diabetes Care, 49(6), e88-e90. https://doi.org/10.2337/dca26-0020
Paredes, R., Puertas, M. C., Bannister, W., Kisic, M., Cozzi-Lepri, A., Pou, C., Bellido, R., Betancor, G., Bogner, J., Gargalianos, P., Bánhegyi, D., Clotet, B., Lundgren, J., Menéndez-Arias, L., Martinez-Picado, J. & EuroSIDA Study Group (Lars Østergaard, member) (2011). A376S in the connection subdomain of HIV-1 reverse transcriptase confers increased risk of virological failure to nevirapine therapy. Journal of Infectious Diseases, 204(5), 741-52. https://doi.org/10.1093/infdis/jir385
Paolini, L., Monguió-Tortajada, M., Costa, M., Antenucci, F., Barilani, M., Clos-Sansalvador, M., Andrade, A. C., Driedonks, T. A. P., Giancaterino, S., Kronstadt, S. M., Mizenko, R. R., Nawaz, M., Osteikoetxea, X., Pereira, C., Shrivastava, S., Boysen, A. T., van de Wakker, S. I., van Herwijnen, M. J. C., Wang, X. ... Bergese, P. (2022). Large-scale production of extracellular vesicles: Report on the “massivEVs” ISEV workshop. Journal of Extracellular Biology, 1(10), Article e63. https://doi.org/10.1002/jex2.63